JPRN-jRCT2080221909未知3 期
Randomized, double-blind, placebo-controlled study on FPF1100NW monotherapy with early Parkinson's disease patients (Phase III study)
FP Pharmaceutical Corp.0 个研究点目标入组 280 人开始时间: 2012年9月6日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 280
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 74age old（—）
- 性别
- All
入选标准
- •Main inclusion criteria
- •Parkinson's disease patients who have no history of previous treatment with anti-Parkinson's disease drugs
- •Within five years after onset of motor symptoms
- •Modified Hoehn & Yahr rating stage I - III
- •UPDRS part III total score 10 or greater
排除标准
- •Main exclusion criteria
- •Patients taking the drugs designated in the exclusion criteria during a certain period of time before starting administration of the investigational drug
- •Patients complicated with serious neurological and mental disorders (e.g. disturbed consciousness, hallucination, delusion, abnormal behaviors, etc.)
- •Patients under epilepsy treatment
- •Patients with advanced complications in the cardiovascular system, liver, kidney, blood or other organs
- •Patients with complication or history of schizophrenia
- •Patients with dependence on CNS stimulants (e.g. amphetamines, cocaine, etc.) or with such history
- •Patients during pregnancy or lactation, or patients who wish to get pregnant during the study
- •Patients who participated in any study using selegiline in the past
研究者
相似试验
进行中（未招募）
1 期
Study to assess the efficacy of homeopathic 2LALERG on symptoms of allergy to grass pollePatients: Allergic Rhinitis and allergic rhinoconjunctivitis in patients with seasonal allergy to grass pollenEUCTR2016-000097-38-BEabo'Life
进行中（未招募）
1 期
Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of cyclosporine mucoadhesive gel at two different concentrations in the topical treatment of oral lichen planus in the oral mucosa.oral lichen planusEUCTR2017-000791-29-ESClínica Universidad de Navarra/Universidad de Navarra28
已完成
3 期
A clinical trial to compare the effects of riboflavin and propranolol in preventive therapy of migraineCTRI/2010/091/000539Dr. Y K Gupta120
已完成
2 期
Randomized, double-blind, placebo-controlled study to evaluate the efficacy of levetiracetam on overcoming neurological deterioration occurring in patients with poor-grade subarachnoid hemorrhagePoor-grade subarachnoid hemorrhageJPRN-UMIN000013507Department of Neurosurgery, Tohoku Graduate School of Medicine80
已完成
不适用
Randomized, double-blind, placebo-controlled study of the tolerability and pharmacokinetics of ascending single (TDU6964) and 14-day repeated (TDR6966) oral doses of SAR501788 and pilot food variability evaluation (FED6965) in healthy young male subjects - Tolerability and pharmacokinetics of 14-day repeated oral doses of SAR501788 in healthy elderly male and female subjects (TDR6967)neuropathies nerve pain10034606NL-OMON32736Sanofi-aventis152